{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:37:41Z","timestamp":1790836661557,"version":"4.1.0"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02924","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T04:26:12Z","timestamp":1545366372000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":190,"title":["Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma"],"prefix":"10.3389","volume":"9","author":[{"given":"Qianquan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/SMJ.0b013e31818005e5","article-title":"Long-term survival after glioblastoma multiforme","volume":"101","author":"Walid","year":"2008","journal-title":"South Med J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1021\/mp1004228","article-title":"The suppressive tumor microenvironment: a challenge in cancer immunotherapy","volume":"8","author":"Vasievich","year":"2011","journal-title":"Mol Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.2174\/0929867311320150004","article-title":"Targeting role of glioma stem cells for glioblastoma multiforme","volume":"20","author":"Zhang","year":"2013","journal-title":"Curr Med Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/labinvest.2017.19","article-title":"Immune microenvironment of gliomas","volume":"97","author":"Gieryng","year":"2017","journal-title":"Lab Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stem.2017.10.002","article-title":"Targeting glioma stem cell-derived pericytes disrupts the blood-tumor barrier and improves chemotherapeutic efficacy","volume":"21","author":"Zhou","year":"2017","journal-title":"Cell Stem Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fonc.2017.00143","article-title":"The impact of the tumor microenvironment on the properties of glioma stem-like cells","volume":"7","author":"Audia","year":"2017","journal-title":"Front Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","article-title":"Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma","volume":"64","author":"Galli","year":"2004","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s13238-010-0078-y","article-title":"Cancer stem cells in glioblastoma\u2013molecular signaling and therapeutic targeting","volume":"1","author":"Huang","year":"2010","journal-title":"Protein Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-06-4180","article-title":"CD133+ and CD133\u2212 glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles","volume":"67","author":"Beier","year":"2007","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1227\/01.neu.0000316019.28421.95","article-title":"Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas","volume":"62","author":"Ogden","year":"2008","journal-title":"Neurosurgery"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.stem.2012.12.007","article-title":"The sox family of transcription factors: versatile regulators of stem and progenitor cell fate","volume":"12","author":"Sarkar","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cell.2013.02.006","article-title":"Jmjd3 inhibits reprogramming by upregulating expression of INK4a\/Arf and targeting PHF20 for ubiquitination","volume":"152","author":"Zhao","year":"2013","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","article-title":"Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells","volume":"157","author":"Suva","year":"2014","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.20929","article-title":"Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival","volume":"117","author":"Pallasch","year":"2005","journal-title":"Int. J. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/jmcb\/mjy007","article-title":"PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4","volume":"10","author":"Long","year":"2018","journal-title":"J Mol Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/neuonc\/nor113","article-title":"Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile","volume":"13","author":"Hagerstrand","year":"2011","journal-title":"Neuro-Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1517\/14728222.2016.1151002","article-title":"mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance","volume":"20","author":"Garros-Regulez","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/neuonc\/not090","article-title":"MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells","volume":"15","author":"Rani","year":"2013","journal-title":"Neuro-Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2014.05.005","article-title":"Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma","volume":"26","author":"Vanner","year":"2014","journal-title":"Cancer Cell"},{"key":"B25","first-page":"14","article-title":"Monoclonal antibodies in cancer therapy","volume":"12","author":"Scott","year":"2012","journal-title":"Cancer Immun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/156800912799277557","article-title":"Targeting EGFR for treatment of glioblastoma: molecular basis to overcome resistance","volume":"12","author":"Taylor","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"B27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/WCO.0b013e328359b0bc","article-title":"Epidermal growth factor receptor: a re-emerging target in glioblastoma","volume":"25","author":"Hegi","year":"2012","journal-title":"Curr Opin Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccr.2009.02.011","article-title":"TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma","volume":"15","author":"Penuelas","year":"2009","journal-title":"Cancer Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.stem.2009.08.018","article-title":"Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors","volume":"5","author":"Ikushima","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B30","first-page":"945","article-title":"TGF-\u03b2 signaling and its targeting for glioma treatment","volume":"5","author":"Han","year":"2015","journal-title":"Am J Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11060-015-1729-x","article-title":"Glioblastoma stem cells and stem cell-targeting immunotherapies","volume":"123","author":"Esparza","year":"2015","journal-title":"J Neurooncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2174\/0929867054367248","article-title":"Dendritic cells: activation and maturation\u2013applications for cancer immunotherapy","volume":"12","author":"Sheng","year":"2005","journal-title":"Curr Med Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jconrel.2018.01.004","article-title":"Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma","volume":"272","author":"Zhu","year":"2018","journal-title":"J Control Release"},{"key":"B35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-017-1202-z","article-title":"A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients","volume":"15","author":"Inoges","year":"2017","journal-title":"J Transl Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00262-015-1754-9","article-title":"Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies","volume":"65","author":"Finocchiaro","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00262-013-1453-3","article-title":"Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma","volume":"62","author":"Vik-Mo","year":"2013","journal-title":"Cancer Immunol Immunother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00262-012-1319-0","article-title":"Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma","volume":"62","author":"Phuphanich","year":"2013","journal-title":"Cancer Immunol Immunother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1158\/1078-0432.CCR-17-3061","article-title":"Cross-talk between T Cells and hematopoietic stem cells during adoptive cellular therapy for malignant glioma","volume":"24","author":"Wildes","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1158\/0008-5472.CAN-13-1942","article-title":"Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma","volume":"74","author":"Favaro","year":"2014","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrd.2017.84","article-title":"CAR T therapies drive into new terrain","volume":"16","author":"Kingwell","year":"2017","journal-title":"Nat Rev Drug Discov."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3389\/fimmu.2018.01104","article-title":"Perspectives on chimeric antigen receptor T-Cell immunotherapy for solid tumors","volume":"9","author":"Kosti","year":"2018","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","article-title":"Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T Cells","volume":"7","author":"Gust","year":"2017","journal-title":"Cancer Discov."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1319","article-title":"Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia","author":"Santomasso","year":"2018","journal-title":"Cancer Discov."},{"key":"B45","first-page":"22","article-title":"Engineering chimeric antigen receptor T cells to treat glioblastoma","volume":"6","author":"Choi","year":"2017","journal-title":"J Target Ther Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1078-0432.CCR-09-1322","article-title":"HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors","volume":"16","author":"Ahmed","year":"2010","journal-title":"Clin Cancer Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/1078-0432.CCR-11-1669","article-title":"Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells","volume":"18","author":"Brown","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/156652309789753356","article-title":"Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas","volume":"9","author":"Jiang","year":"2009","journal-title":"Curr Gene Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s11262-017-1488-1","article-title":"Oncolytic viruses: adenoviruses","volume":"53","author":"Niemann","year":"2017","journal-title":"Virus Genes"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/jnci\/djm102","article-title":"Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death","volume":"99","author":"Jiang","year":"2007","journal-title":"J Natl Cancer Inst."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I Study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J Clin Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.4049\/jimmunol.180.11.7673","article-title":"Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma","volume":"180","author":"Waziri","year":"2008","journal-title":"J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1080\/21645515.2017.1303582","article-title":"Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme","volume":"13","author":"Sokratous","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nm1201-1356","article-title":"Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment","volume":"7","author":"Priller","year":"2001","journal-title":"Nat Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.expneurol.2003.11.005","article-title":"Hematopoietic origin of microglial and perivascular cells in brain","volume":"186","author":"Hess","year":"2004","journal-title":"Exp Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/ATVBAHA.113.300168","article-title":"Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions","volume":"33","author":"Mantovani","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2016.12.013","article-title":"CCL2\/CCR2 signaling pathway in glioblastoma multiforme","volume":"103","author":"Vakilian","year":"2017","journal-title":"Neurochem Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.10679","article-title":"Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas","volume":"54","author":"Platten","year":"2003","journal-title":"Ann Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1158\/1078-0432.CCR-12-3725","article-title":"S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages","volume":"19","author":"Wang","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma cancer stem cells induce immunosuppressive macrophages\/microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro-Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/glia.22298","article-title":"Comparison of polarization properties of human adult microglia and blood-derived macrophages","volume":"60","author":"Durafourt","year":"2012","journal-title":"Glia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lungcan.2017.01.003","article-title":"The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation","volume":"106","author":"Iriki","year":"2017","journal-title":"Lung Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1038\/onc.2017.129","article-title":"MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2217\/imt.13.102","article-title":"Targeting tumor-infiltrating macrophages to combat cancer","volume":"5","author":"Panni","year":"2013","journal-title":"Immunotherapy"},{"key":"B69","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J Hematol Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbcan.2014.10.003","article-title":"Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle","volume":"1846","author":"Wurdinger","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","article-title":"The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance","volume":"222","author":"Allavena","year":"2008","journal-title":"Immunol Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"21659","DOI":"10.1073\/pnas.1007654108","article-title":"The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes","volume":"107","author":"Bellora","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/jcp.24260","article-title":"Tumor associated macrophages and neutrophils in tumor progression","volume":"228","author":"Galdiero","year":"2013","journal-title":"J Cell Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e26148","DOI":"10.4161\/onci.26148","article-title":"Assessing T-cell responses in anticancer immunotherapy: dendritic cells or myeloid-derived suppressor cells?","volume":"2","author":"Escors","year":"2013","journal-title":"Oncoimmunology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5114\/wo.2016.64592","article-title":"Myeloid-derived suppressor cells in gliomas","volume":"20","author":"Gieryng","year":"2016","journal-title":"Contemp Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00262-010-0855-8","article-title":"Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity","volume":"59","author":"Ostrand-Rosenberg","year":"2010","journal-title":"Cancer Immunol Immunother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12017-015-8362-x","article-title":"The dynamics of interactions among immune and glioblastoma cells","volume":"17","author":"Eder","year":"2015","journal-title":"Neuromolecular Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J Exp Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clim.2016.10.008","article-title":"Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy","volume":"189","author":"Kamran","year":"2016","journal-title":"Clin. Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1010428317699797","DOI":"10.1177\/1010428317699797","article-title":"Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: potential therapeutic benefit from dapsone, fenofibrate, and ribavirin","volume":"39","author":"Kast","year":"2017","journal-title":"Tumour Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T Cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3892\/ijo.2016.3586","article-title":"Immunological effects of the anti-programmed death-1 antibody on human peripheral blood mononuclear cells","volume":"49","author":"Akiyama","year":"2016","journal-title":"Int J Oncol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/neuonc\/nov280","article-title":"CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients","volume":"18","author":"Dubinski","year":"2016","journal-title":"Neuro-Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","article-title":"Regulatory T cells and cancer","volume":"19","author":"Wang","year":"2007","journal-title":"Curr Opin Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxw025","article-title":"Roles of regulatory T cells in cancer immunity","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Int Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1074-7613(03)00359-5","article-title":"Tumor-specific human CD4+ regulatory T cells and their ligands: implication for immunotherapy","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.174.5.2661","article-title":"Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells","volume":"174","author":"Wang","year":"2005","journal-title":"J Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1113401","article-title":"Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function","volume":"309","author":"Peng","year":"2005","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.clineuro.2013.12.004","article-title":"The role of regulatory T-cells in glioma immunology","volume":"119","author":"Ooi","year":"2014","journal-title":"Clin Neurol Neurosurg."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3389\/fimmu.2017.01451","article-title":"CD4+ and perivascular Foxp3+ T cells in glioma correlate with angiogenesis and tumor progression","volume":"8","author":"Mu","year":"2017","journal-title":"Front Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/neuonc\/nos014","article-title":"Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy","volume":"14","author":"Crane","year":"2012","journal-title":"Neuro-Oncol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1158\/1078-0432.CCR-12-2130","article-title":"IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival","volume":"18","author":"Wainwright","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu Rev Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-015-1849-3","article-title":"The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression","volume":"123","author":"See","year":"2015","journal-title":"J Neurooncol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11060-006-9314-y","article-title":"CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas","volume":"83","author":"El Andaloussi","year":"2007","journal-title":"J Neurooncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/eji.200526168","article-title":"Association of CTLA4 polymorphism with regulatory T cell frequency","volume":"35","author":"Atabani","year":"2005","journal-title":"Eur J Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1215\/15228517-2008-104","article-title":"Regulatory T cells and the PD-L1\/PD-1 pathway mediate immune suppression in malignant human brain tumors","volume":"11","author":"Jacobs","year":"2009","journal-title":"Neuro-Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11060-013-1236-x","article-title":"Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study","volume":"115","author":"Vasco","year":"2013","journal-title":"J Neurooncol."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4030028","article-title":"Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting","author":"Chaudhary","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"B102","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0952-7915(03)00039-6","article-title":"Natural killer cell receptor signaling","volume":"15","author":"Lanier","year":"2003","journal-title":"Curr Opin Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaci.2013.07.006","article-title":"Natural killer cell biology: an update and future directions","volume":"132","author":"Campbell","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B104","first-page":"133","article-title":"Mechanisms of malignant glioma immune resistance and sources of immunosuppression","volume":"10","author":"Gomez","year":"2006","journal-title":"Gene Ther Mol Biol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ajpath.2012.10.021","article-title":"Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-gamma treatments: results from a multicentric study","volume":"182","author":"Wastowski","year":"2013","journal-title":"Am J Pathol."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2015.00083","article-title":"HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapy","author":"Lin","year":"2015","journal-title":"Mol Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro-Oncol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/neuonc\/now061","article-title":"IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression","volume":"18","author":"Zhang","year":"2016","journal-title":"Neuro-Oncol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20122248","article-title":"Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2","volume":"210","author":"Sitrin","year":"2013","journal-title":"J Exp Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fimmu.2017.00930","article-title":"Developmental and functional control of natural killer cells by cytokines","volume":"8","author":"Wu","year":"2017","journal-title":"Front Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu Rev Immunol."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1232221","article-title":"Tumor-associated neutrophils display a distinct N1 profile following TGFbeta modulation: a transcriptomics analysis of pro- vs. antitumor TANs","author":"Shaul","year":"2016","journal-title":"Oncoimmunology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.amjsurg.2017.08.003","article-title":"Cancer-promoting mechanisms of tumor-associated neutrophils","volume":"214","author":"Hurt","year":"2017","journal-title":"Am J Surg."},{"key":"B114","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B115","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.semcancer.2013.02.005","article-title":"Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression","volume":"23","author":"Dumitru","year":"2013","journal-title":"Semin Cancer Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.semcancer.2013.02.003","article-title":"Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth","volume":"23","author":"Tazzyman","year":"2013","journal-title":"Semin Cancer Biol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s12885-015-1629-7","article-title":"Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma","volume":"15","author":"Han","year":"2015","journal-title":"BMC Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.4049\/jimmunol.0900305","article-title":"Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer","volume":"183","author":"Nasser","year":"2009","journal-title":"J Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbadis.2014.10.014","article-title":"Nucleotide receptors control IL-8\/CXCL8 and MCP-1\/CCL2 secretions as well as proliferation in human glioma cells","volume":"1852","author":"Braganhol","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1189\/jlb.0310172","article-title":"Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells","volume":"88","author":"Pelletier","year":"2010","journal-title":"J Leukoc Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20040624","article-title":"Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-\u03baB activity","volume":"201","author":"Walmsley","year":"2005","journal-title":"J. Exp Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1158\/1078-0432.CCR-13-1279","article-title":"Neutrophils promote the malignant glioma phenotype through S100A4","volume":"20","author":"Liang","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ijc.24448","article-title":"IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer","volume":"125","author":"Rotondo","year":"2009","journal-title":"Int J Cancer"},{"key":"B125","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1101\/gad.294991.116","article-title":"Mutant IDH1 regulates the tumor-associated immune system in gliomas","volume":"31","author":"Amankulor","year":"2017","journal-title":"Genes Dev."},{"key":"B126","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol Rev."},{"key":"B127","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol Immunol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.4161\/onci.25443","article-title":"B cell-regulated immune responses in tumor models and cancer patients","author":"Fremd","year":"2013","journal-title":"Oncoimmunology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-12-3450","article-title":"Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"20044","DOI":"10.1038\/srep20044","article-title":"IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses","volume":"6","author":"Nova-Lamperti","year":"2016","journal-title":"Sci Rep."},{"key":"B131","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00011-016-0947-9","article-title":"Regulatory B10 cells play a protective role in severe acute pancreatitis","volume":"65","author":"Qiu","year":"2016","journal-title":"Inflamm Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40425-016-0145-x","article-title":"B cell regulation of the anti-tumor response and role in carcinogenesis","volume":"4","author":"Schwartz","year":"2016","journal-title":"J Immunother Cancer"},{"key":"B134","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B135","doi-asserted-by":"publisher","first-page":"33486","DOI":"10.18632\/oncotarget.5588","article-title":"CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"B136","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2014.10.005","article-title":"Glioma cell-derived placental growth factor induces regulatory B cells","volume":"57","author":"Han","year":"2014","journal-title":"Int J Biochem Cell Biol."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105350","article-title":"Glioma-derived ADAM10 induces regulatory B cells to suppress CD8+ T cells","author":"Ye","year":"2014","journal-title":"PLoS ONE"},{"key":"B138","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu Rev Pathol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/imm.12380","article-title":"Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment","volume":"143","author":"Kumar","year":"2014","journal-title":"Immunology"},{"key":"B140","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol Cell"},{"key":"B141","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1159\/000464429","article-title":"Hypoxia enhances immunosuppression by inhibiting CD4+ Effector T Cell function and promoting treg activity","volume":"41","author":"Westendorf","year":"2017","journal-title":"Cell Physiol Biochem."},{"key":"B143","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/1078-0432.CCR-15-2888","article-title":"Survival and proliferation of neural progenitor-derived glioblastomas under hypoxic stress is controlled by a CXCL12\/CXCR4 autocrine-positive feedback mechanism","volume":"23","author":"Calinescu","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","article-title":"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression","volume":"70","author":"Doedens","year":"2010","journal-title":"Cancer Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/eji.200838318","article-title":"Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha","volume":"38","author":"Ben-Shoshan","year":"2008","journal-title":"Eur J Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/onc.2017.404","article-title":"Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia","volume":"37","author":"Almiron","year":"2017","journal-title":"Oncogene"},{"key":"B148","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.4049\/jimmunol.1001455","article-title":"Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression","volume":"186","author":"Goodman","year":"2011","journal-title":"J Immunol."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006615","article-title":"The role of STAT3 and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"B150","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med."},{"key":"B151","doi-asserted-by":"publisher","first-page":"80521","DOI":"10.18632\/oncotarget.11825","article-title":"Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-\u03b2 and M-CSFR","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"B152","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/HP.S50269","article-title":"HIF-mediated innate immune responses: cell signaling and therapeutic implications","volume":"2","author":"Harris","year":"2014","journal-title":"Hypoxia"},{"key":"B153","doi-asserted-by":"publisher","first-page":"63690","DOI":"10.18632\/oncotarget.11628","article-title":"Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2","volume":"7","author":"Yaghi","year":"2016","journal-title":"Oncotarget"},{"key":"B154","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"key":"B155","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1158\/1535-7163.MCT-09-0734","article-title":"Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway","volume":"9","author":"Wei","year":"2010","journal-title":"Mol Cancer Ther."},{"key":"B156","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B157","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"B158","first-page":"2514","article-title":"Combined VEGFR and CTLA-4 blockade increases the antigen-presenting function of intratumoral DCs and reduces the suppressive capacity of intratumoral MDSCs","volume":"6","author":"Du","year":"2016","journal-title":"Am J Cancer Res."},{"key":"B159","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/82_2017_61","article-title":"CTLA-4, an essential immune-checkpoint for T-Cell activation","volume":"410","author":"Chikuma","year":"2017","journal-title":"Curr Top Microbiol Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1182\/blood-2011-11-388918","article-title":"Basis of CTLA-4 function in regulatory and conventional CD4+ T cells","volume":"119","author":"Tai","year":"2012","journal-title":"Blood"},{"key":"B161","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/mi.2012.75","article-title":"CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria","volume":"6","author":"Barnes","year":"2013","journal-title":"Mucosal Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","journal-title":"Trends Mol Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies","volume":"6","author":"Shi","year":"2013","journal-title":"J Hematol Oncol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med."},{"key":"B168","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.7150\/jca.18683","article-title":"PD-L1 expression is associated with FOXP3+ regulatory T-cell infiltration of soft tissue sarcoma and poor patient prognosis","volume":"8","author":"Que","year":"2017","journal-title":"J Cancer"},{"key":"B169","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/14796694.4.3.433","article-title":"Combating immunosuppression in glioma","volume":"4","author":"Vega","year":"2008","journal-title":"Future Oncol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1158\/1078-0432.CCR-14-0820","article-title":"Blocking immunosuppressive checkpoints for glioma therapy: the more the Merrier!","volume":"20","author":"Castro","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B171","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1158\/1078-0432.CCR-14-0832","article-title":"Immunotherapy for primary brain tumors: no longer a matter of privilege","volume":"20","author":"Fecci","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032614","article-title":"Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients","author":"Fong","year":"2012","journal-title":"PLoS ONE"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/ijc.30877","article-title":"Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade","volume":"141","author":"Dejaegher","year":"2017","journal-title":"Int J Cancer"},{"key":"B174","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1128\/MCB.00319-13","article-title":"PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2","volume":"33","author":"Patsoukis","year":"2013","journal-title":"Mol Cell Biol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"key":"B176","doi-asserted-by":"publisher","first-page":"14754","DOI":"10.1038\/ncomms14754","article-title":"Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun."},{"key":"B177","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/cr.2016.155","article-title":"Immune targets and neoantigens for cancer immunotherapy and precision medicine","volume":"27","author":"Wang","year":"2017","journal-title":"Cell Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/brain\/aww355","article-title":"Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis","volume":"140","author":"Poon","year":"2017","journal-title":"Brain"},{"key":"B179","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2119\/molmed.2011.00217","article-title":"Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling","volume":"18","author":"Coniglio","year":"2012","journal-title":"Mol Med."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3018","article-title":"The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas","author":"Quail","year":"2016","journal-title":"Science"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","article-title":"COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells","volume":"71","author":"Fujita","year":"2011","journal-title":"Cancer Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00262-011-1196-y","article-title":"Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors","volume":"61","author":"Eberstal","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"B184","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00262-014-1561-8","article-title":"Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells","volume":"63","author":"Kosaka","year":"2014","journal-title":"Cancer Immunol Immunother."},{"key":"B185","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-010-0473-5","article-title":"Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy","volume":"104","author":"Zhu","year":"2011","journal-title":"J Neurooncol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ymthe.2018.02.001","article-title":"Adoptive Transfer of IL13Ralpha2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma","volume":"26","author":"Pituch","year":"2018","journal-title":"Mol. Ther."},{"key":"B187","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ymthe.2016.10.003","article-title":"Immunosuppressive myeloid cells' blockade in the glioma microenvironment enhances the efficacy of immune-stimulatory gene therapy","volume":"25","author":"Kamran","year":"2017","journal-title":"Mol Ther."},{"key":"B188","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2217\/imt.12.64","article-title":"Treg infiltration in glioma: a hurdle for antiglioma immunotherapy","volume":"4","author":"Vandenberk","year":"2012","journal-title":"Immunotherapy"},{"key":"B189","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B190","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40425-016-0132-2","article-title":"Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma","volume":"4","author":"Patel","year":"2016","journal-title":"J Immunother Cancer"},{"key":"B191","doi-asserted-by":"publisher","first-page":"952469","DOI":"10.1155\/2013\/952469","article-title":"Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain","volume":"2013","author":"Maes","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneurol.2015.139","article-title":"Prospects of immune checkpoint modulators in the treatment of glioblastoma","volume":"11","author":"Preusser","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/14712598.2017.1305353","article-title":"Single vs. combination immunotherapeutic strategies for glioma","volume":"17","author":"Chandran","year":"2017","journal-title":"Expert Opin Biol Ther."},{"key":"B194","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","article-title":"Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas","volume":"86","author":"Zeng","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B195","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/1078-0432.CCR-15-1535","article-title":"Combination Therapy with Anti-PD-1, Anti-TIM-3, and focal radiation results in regression of murine gliomas","volume":"23","author":"Kim","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21873\/anticanres.11285","article-title":"Advances in experimental targeted therapy and immunotherapy for patients with glioblastoma multiforme","volume":"37","author":"Polivka","year":"2017","journal-title":"Anticancer Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02924\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T04:26:19Z","timestamp":1545366379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02924\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":196,"alternative-id":["10.3389\/fimmu.2018.02924"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02924","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"article-number":"2924"}}